Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (AnPAF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by Institute of Cardiology, Warsaw, Poland
Sponsor:
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland
ClinicalTrials.gov Identifier:
NCT01527279
First received: February 2, 2012
Last updated: February 4, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
No publications provided by Institute of Cardiology, Warsaw, Poland

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):